Pascal is a biotechnology company advancing innovative therapies for serious diseases. In addition to its own research development programs, Pascal also provides consulting and contract research services to early stage companies.
Pascal Biosciences is a public company traded on the TSX Venture Exchange under the symbol “PAS”, on the Frankfurt Stock Exchange (FSE) under the symbol “6PB.F”, and on the OTC with the symbol PSCBF.
Pascal Biosciences Inc. files financial and other information about the performance of the company on SEDAR (the System for Electronic Document and Analysis and Retrieval) in Canada. Pascal Biosciences Inc. on SEDAR has been used to electronically file securities related information with Canadian Securities Administrators.
To access Pascal’s regulatory filings and financials, please click on the link below to the SEDAR website.
